With a market cap of $183 billion, AT&T Inc. (T) is a global provider of telecommunications and technology services operating through its Communications and Latin America segments. It has grown into one of the world’s largest providers of wireless, broadband, and communication services.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and AT&T fits this criterion perfectly. The company offers a wide range of consumer and business solutions, including wireless voice and data services, internet connectivity, and related devices.
Shares of the Dallas, Texas-based company have slipped 13.3% from its 52-week high of $29.79. The stock has declined 9.6% over the past three months, lagging behind the Nasdaq Composite’s ($NASX) 7.8% gain over the same time frame.
Longer term, AT&T stock is up 13.4% on a YTD basis, underperforming NASX’s 20.2% increase. Moreover, shares of the company have risen 11.8% over the past 52 weeks, compared to NASX’s 21.1% return over the same time frame.
The stock has been trading below its 50-day moving average since late September.
AT&T shares fell 1.9% after the company posted Q3 2025 on Oct. 22 as investors reacted to flat adjusted EPS of $0.54 despite strong subscriber additions. Concerns also rose over ongoing structural pressures, including a 7.8% decline in Business Wireline revenue and increased operating costs tied to higher equipment sales, legal settlements of ~$0.4 billion, and rising depreciation from network upgrades.
In contrast, rival Verizon Communications Inc. (VZ) has lagged behind AT&T stock. VZ stock has risen 2.2% on a YTD basis and declined 7.9% over the past 52 weeks.
Despite AT&T’s weak performance relative to the Nasdaq, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from 29 analysts in coverage, and the mean price target of $29.80 is a premium of 15.4% to current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
- Dear UnitedHealth Stock Fans, Mark Your Calendars for January 30
- As Founder Ray Dalio Warns the Market Is in a Bubble, Bridgewater Associates Just Bought CoreWeave Stock
- Eli Lilly’s Stock Price Has Fattened Up Like a Thanksgiving Turkey. Time to (Options) Collar That Green!
- With a 6.7% Yield and 27 Years of Dividend Hikes, Is This Stock a Buy Today?
